Solana Co — Director's Dealing 2017

Dec 26, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2017-12-22

Reporting Person: ANDREEFF DANE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-22	Class A Common Stock	P	141027	$1.96	Acquired	1485796	Indirect
2017-12-22	Class A Common Stock	P	30927	$1.96	Acquired	325338	Indirect
2017-12-22	Class A Common Stock	P	83147	$1.96	Acquired	789435	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-12-22	Warrant (Right to Buy)	$2.45	P	141027	Acquired	2020-12-22	Class A Common Stock (141027)	Indirect
2017-12-22	Warrant (Right to Buy)	$2.45	P	30927	Acquired	2020-12-22	Class A Common Stock (30927)	Indirect
2017-12-22	Warrant (Right to Buy)	$2.45	P	83147	Acquired	2020-12-22	Class A Common Stock (83147)	Indirect

Footnotes

F1: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $1.96.

F2: The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP, and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F3: The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I, and as such may be deemed to beneficially own the securities held by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F4: The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I, and as such may be deemed to beneficially own the securities held by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F5: Immediately exercisable.